Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients

American Journal of Kidney Diseases

Volumn 62, Issue 3, 2013, Pages 568-576

  Shoji, Tetsuo ^a   Kakiya, Ryusuke ^a,b   Hayashi, Tomoshige ^a   Tsujimoto, Yoshihiro ^b   Sonoda, Mika ^a   Shima, Hideaki ^a   Mori, Katsuhito ^a   Fukumoto, Shinya ^a   Tahara, Hideki ^a   Shioi, Atushi ^a   Tabata, Tsutomu ^b   Emoto, Masanori ^a   Nishizawa, Yoshiki ^a   Inaba, Masaaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Inoue Hospital   (Japan)

Author keywords

arachidonic acid (AA); cardiovascular disease; docosahexaenoic acid (DHA); eicosapentaenoic acid (EPA); hemodialysis; n 3 polyunsaturated fatty acid (PUFA)

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; POLYUNSATURATED FATTY ACID;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; ISCHEMIC HEART DISEASE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK ASSESSMENT; VALVULAR HEART DISEASE;

ARACHIDONIC ACID (AA); CARDIOVASCULAR DISEASE; DOCOSAHEXAENOIC ACID (DHA); EICOSAPENTAENOIC ACID (EPA); HEMODIALYSIS; N-3-POLYUNSATURATED FATTY ACID (PUFA);

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS;

EID: 84883209472     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.02.362     Document Type: Article

References (26)

1. J. Dyerberg, H.O. Bang, E. Stoffersen, S. Moncada, J.R. Vane Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2 8081 1978 117 119
2. H.O. Bang, J. Dyerberg, H.M. Sinclair The composition of the Eskimo food in North Western Greenland Am J Clin Nutr 33 12 1980 2657 2661
3. H. Iso, M. Kobayashi, J. Ishihara Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I Circulation 113 2 2006 195 202
4. W.S. Harris, D. Mozaffarian, E. Rimm Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention Circulation 119 6 2009 902 907
5. P.M. Kris-Etherton, W.S. Harris, L.J. Appel Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circulation 106 21 2002 2747 2757
6. R.M. Krauss, R.H. Eckel, B. Howard AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association Circulation 102 18 2000 2284 2299
7. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico Lancet 354 9177 1999 447 455
8. M. Yokoyama, H. Origasa, M. Matsuzaki Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Lancet 369 9567 2007 1090 1098
9. A.N. Friedman, S.M. Moe, S.M. Perkins, Y. Li, B.A. Watkins Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis Am J Kidney Dis 47 6 2006 1064 1071
10. K. Hamazaki, Y. Terashima, M. Itomura The relationship between n-3 long-chain polyunsaturated fatty acids and pulse wave velocity in diabetic and non-diabetic patients under long-term hemodialysis A horizontal study Clin Nephrol 71 5 2009 508 513
11. K. Hamazaki, Y. Terashima, M. Itomura Docosahexaenoic acid is an independent predictor of all-cause mortality in hemodialysis patients Am J Nephrol 33 2 2011 105 110
12. A. Kooshki, F.A. Taleban, H. Tabibi, M. Hedayati Effects of omega-3 fatty acids on serum lipids, lipoprotein(a), and hematologic factors in hemodialysis patients Ren Fail 33 9 2011 892 898
13. C.E. Lok, L. Moist, B.R. Hemmelgarn Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial JAMA 307 17 2012 1809 1816
14. M. Svensson, E.B. Schmidt, K.A. Jorgensen, J.H. Christensen N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial Clin J Am Soc Nephrol 1 4 2006 780 786
15. J.V. Donadio Jr, T.S. Larson, E.J. Bergstralh, J.P. Grande A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy J Am Soc Nephrol 12 4 2001 791 799
16. R.J. Hogg, L. Fitzgibbons, C. Atkins, N. Nardelli, R.C. Bay Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent Clin J Am Soc Nephrol 1 6 2006 1167 1172
17. N. Yanagisawa, K. Shimada, T. Miyazaki Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an urban area J Atheroscler Thromb 17 3 2010 285 294
18. T. Domei, H. Yokoi, S. Kuramitsu Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention Circ J 76 2 2012 423 429
19. R. Kakiya, T. Shoji, T. Hayashi Decreased serum adrenal androgen dehydroepiandrosterone sulfate and mortality in hemodialysis patients Nephrol Dial Transplant 27 10 2012 3915 3922
20. M.H. Davidson, D. Kling, K.C. Maki Novel developments in omega-3 fatty acid-based strategies Curr Opin Lipidol 22 6 2011 437 444
21. T. Miyajima, T. Tsujino, K. Saito, M. Yokoyama Effects of eicosapentaenoic acid on blood pressure, cell membrane fatty acids, and intracellular sodium concentration in essential hypertension Hypertens Res 24 5 2001 537 542
22. F. Thies, J.M. Garry, P. Yaqoob Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial Lancet 361 9356 2003 477 485
23. S. Nodari, M. Triggiani, U. Campia Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy J Am Coll Cardiol 57 7 2011 870 879
24. D. Mozaffarian, J.H. Wu Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events J Am Coll Cardiol 58 20 2011 2047 2067
25. N. Nakamura, T. Fujita, R. Kumasaka Serum lipid profile and plasma fatty acid composition in hemodialysis patients.- comparison with chronic kidney disease patients In Vivo 22 5 2008 609 611
26. J. Bosch, H.C. Gerstein, G.R. Dagenais n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia N Engl J Med 367 4 2012 309 318